Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Sareum Share News (SAR)
SAR Share
Price
SAR Share
News
SAR Share
Chat26
SAR Share
Trades12
SAR
Live RNS
SAR Share
Charts
SAR Level 2
Console
SAR Live
Share Price
SAR Broker
Ratings
SAR Directors
Deals
SAR Financial
Diary
SAR
Fundamentals
SAR Short
Positions
SAR
Media
SAR Company
Research
SAR Company
Timeline
Share Price Information for Sareum (SAR)
Last checked at -
Last checked at 
Intraday Sareum Share Chart
Sareum News
Sareum looks at options as GSK division returns cancer drug candidate
(Sharecast News) - Biotechnology developer Sareum announced on Monday that GSK subsidiary Sierra Oncology has returned clinical study reports and asso...
Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer
(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study report...
TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Sareum confident despite recent setbacks
(Sharecast News) - Autoimmune and cancer-focussed biotechnology company Sareum said in an update on Friday that it remained "confident" despite some r...
AIM WINNERS & LOSERS: Time Finance jumps on strong first-half results
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
IN BRIEF: Sareum salutes publication of SRA737 combination trial data
Sareum Holdings PLC - Cambridge, England-based biotechnology company focused on developing kinase inhibitors for autoimmune disease & cancer - Says it...
IN BRIEF: Sareum widens annual loss; considers future of SRA737
Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - In the year ended June 30, pretax loss widens to GB...
Follow the stocks
